Journal
HUMAN MOLECULAR GENETICS
Volume 18, Issue 14, Pages 2693-2699Publisher
OXFORD UNIV PRESS
DOI: 10.1093/hmg/ddp193
Keywords
-
Funding
- MRC [G0000934, G0600329] Funding Source: UKRI
- Medical Research Council [G0600329, G0000934] Funding Source: researchfish
- National Institute for Health Research [NF-SI-0508-10299] Funding Source: researchfish
- Versus Arthritis
- Cancer Research UK [18475] Funding Source: researchfish
- Arthritis Research UK [17552, 18475] Funding Source: Medline
- Medical Research Council [G0600329, G0000934] Funding Source: Medline
- Versus Arthritis [18475] Funding Source: Medline
- Wellcome Trust [068545/Z/02, 061858, 090532] Funding Source: Medline
Ask authors/readers for more resources
The most consistent finding derived from the WTCCC GWAS for rheumatoid arthritis (RA) was association to a SNP at 6q23. We performed a fine-mapping of the region in order to search the 6q23 region for additional disease variants. 3962 RA patients and 3531 healthy controls were included in the study. We found 18 SNPs associated with RA. The SNP showing the strongest association was rs6920220 [P = 2.6 x 10(-6), OR (95% CI) 1.22 (1.13-1.33)]. The next most strongly associated SNP was rs13207033 [P = 0.0001, OR (95% CI) 0.86 (0.8-0.93)] which was perfectly correlated with rs10499194, a SNP previously associated with RA in a US/European series. Additionally, we found a number of new potential RA markers, including rs5029937, located in the intron 2 of TNFAIP3. Of the 18 associated SNPs, three polymorphisms, rs6920220, rs13207033 and rs5029937, remained significant after conditional logistic regression analysis. The combination of the carriage of both risk alleles of rs6920220 and rs5029937 together with the absence of the protective allele of rs13207033 was strongly associated with RA when compared with carriage of none [OR of 1.86 (95% CI) (1.51-2.29)]. This equates to an effect size of 1.50 (95% CI 1.21-1.85) compared with controls and is higher than that obtained for any SNP individually. This is the first study to show that the confirmed loci from the GWA studies, that confer only a modest effect size, could harbour a significantly greater effect once the effect of additional risk variants are accounted for.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available